Heron Therapeutics | HRTX - Credores Comerciais





Credores Comerciais Alterar Data
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 45.36M 8.64M 2025-12
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Anika Therapeutics USD 6.04M 1.31M 2025-12
Arrowhead Research USD 32.94M 15.26M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Insmed USD 79.91M 316K 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 15.15M 2.54M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Surmodics USD 2.79M 400K 2024-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Veracyte USD 4.59M 916K 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12